Join
Live feed
·
INSIDERFilingvia Quantisnow
Lyell Immunopharma Inc. logo

Large owner Innovative Cellular Therapeutics Holdings Ltd disposed of 76,000 shares, decreasing direct ownership by 3% to 2,857,500 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LYEL· Lyell Immunopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LYEL (Lyell Immunopharma Inc.) and more on Quantisnow.